Physician profile
James Murphy
NPI 1023010741
$2,454.37
in general payments reported to CMS, 2019-2025
17 companies · $54.12 in 2025
The $54.12 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $435 · 2021: $506 · 2022: $263 · 2023: $172 · 2024: $21.45 · 2025: $54.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $802.89 | 2019-2023 | Variax |
| Microport Orthopedics INC | $801.80 | 2019-2021 | |
| Smith+Nephew, INC. | $273.44 | 2019-2021 | |
| Heron Therapeutics, INC. | $104.95 | 2021-2022 | |
| Horizon Therapeutics Plc | $83.65 | 2019-2021 | |
| Depuy Synthes Sales INC. | $81.88 | 2022 | |
| Pacira Therapeutics, INC. | $56.04 | 2019-2020 | |
| Embody, INC. | $44.77 | 2023 | |
| Native Surgical, LLC | $38.45 | 2025 | |
| Abbott Laboratories | $37.50 | 2023 | Proclaim |
| Sanara Medtech INC. | $28.38 | 2022 | |
| Paratek Pharmaceuticals, INC. | $24.79 | 2020 | |
| Merck Sharp & Dohme LLC | $21.45 | 2024 | Pifeltro |
| Vertex Pharmaceuticals Incorporated | $15.67 | 2025 | |
| Supreme Orthopedic Systems, LLC | $13.70 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $12.59 | 2019 | |
| Viiv Healthcare Company | $12.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.